We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




MRI Reveals Early Impact of Hypertension on Dementia Risk

By MedImaging International staff writers
Posted on 11 Jul 2018
Print article
Image: Cerebral MRIs of two women 67 years of age without (left) and with (right) hypertension. The subject with hypertension had several deep and periventricular white matter lesions (arrows) (Photo courtesy of ResearchGate).
Image: Cerebral MRIs of two women 67 years of age without (left) and with (right) hypertension. The subject with hypertension had several deep and periventricular white matter lesions (arrows) (Photo courtesy of ResearchGate).
A new study shows how magnetic resonance imaging (MRI) can reveal previously undetectable white matter (WM) brain damage induced by hypertension, a major risk factor for dementia.

Researchers at IRCCS Neuromed (Pozzilli, Italy) and Sapienza University (Rome, Italy; www.uniroma1.it) conducted a study involving 42 outpatients (40-65 years of age), of whom 23 were hypertensive and 19 normotensive. The researchers first measured the cognitive performance of study participants with no signs of dementia or structural brain changes (as determined by a neuroradiologist), based on conventional MRI on T1 and AX DP/T2 scans. They then repeated imaging using WM fiber-tracking technology on a GE Healthcare (GE; Little Chalfont, United Kingdom; www.gehealthcare.com) 3T Signa Horizon scanner.

In addition, a blinded, certified psychologist tested cognitive function and looked for any impairment of activities of daily living at baseline. Participants then underwent Montreal Cognitive Assessment (MoCA) neuropsychological testing. When specific MoCA cognitive subdomains were analyzed, the hypertensive group displayed significantly impaired memory, executive function, attention, and language domains, and scored worse on verbal paired-associate learning. Hypertension also appeared to impair executive function, as measured on the Stroop test.

When comparing WM finding between those with and without hypertension, specific signatures for dementia risk among hypertensive patients involved deterioration of projection fibers of the right anterior thalamic radiation (ATR), association fibers of the right superior longitudinal fasciculus (SLF), and callosum fibers of the forceps minor (FMI). The researchers concluded that WM tracking could identify patients in initial stages of brain damage that could benefit from therapies aimed at limiting the transition to dementia and neurodegeneration. The study was published on June 12, 2018, in Cardiovascular Research.

“All hypertensive participants were taking antihypertensive therapy, suggesting that an efficient anti-hypertensive therapy is not sufficient to exclude the onset of vascular dementia or protect the brain from white matter microstructural damage,” said lead author graduate student Lorenzo Carnevale, MSc, of NeuroMed. “Our results point out a big issue in current cardiovascular diseases treatment: We can't ignore the brain. Current therapies are not tailored to ensure at the same time cardiovascular protection and cognitive function protection.”

The ATR is a projection fiber that connects the thalamus's anterior nucleus to the anterior cingulate gyrus and frontal cortex, and ATR damage is associated with impaired memory. The SLF connects the cerebrum parietal and occipital and temporal lobes with the ipsilateral frontal cortices; it facilitates the formation of a bidirectional neural network necessary for cognitive functions, such as attention, memory, emotions, and language. The FMI connects the frontal lobes' lateral and medial surfaces, crosses the midline via the genu of the corpus callosum, and has been linked to processing speed tasks.

Related Links:
IRCCS Neuromed

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Digital Radiography Generator
meX+20BT lite
New
Computed Tomography (CT) Scanner
Aquilion Serve SP
New
Portable Radiology System
DRAGON ELITE & CLASSIC

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.